Latest Chikungunya Stories
Researchers have developed a new candidate vaccine to protect against chikungunya virus, a mosquito-borne pathogen that produces an intensely painful and often chronic arthritic disease that has stricken millions of people in India, Southeast Asia and Africa.
An experimental research carried out in Sant Cugat del VallÃ¨s and RubÃ, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos (Aedes albopictus).
The ten studies in this special issue document the substantial and growing burden of dengue in the Americas, Africa and Asia, and the burden of a chikungunya outbreak in India.
JAKARTA, Indonesia, June 14, 2011 /PRNewswire/ -- The Association of Southeast Asian Nations (ASEAN) launched the first ASEAN Dengue Day today in Indonesia, with related events occurring throughout the ASEAN member states.
What causes a virus to suddenly begin infecting large numbers of people?
MENLO PARK, Calif., May 5, 2011 /PRNewswire/ -- In parts of the world where dengue fever is common, other viral infections are often misdiagnosed. Such misdiagnosis is a waste not only of time and money.
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS (NYSE Euronext: VLS), a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
ROCKVILLE, Md., July 15 /PRNewswire/ -- MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that the National Institutes of Health (NIH) has awarded the company three new grants representing total funding of $9.8 million.
Mosquito-borne virus has infected millions of people in Asia, Africa and Europe.
A study published online on February 1 in the Journal of Experimental Medicine (www.jem.org) shows that antiviral proteins called type I interferons (IFNs) are needed to fend off infection with an exotic mosquito-borne virus called Chikungunya virus.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.